BeOne Medicines
ONC
#735
Rank
HK$265.13 B
Marketcap
HK$2,556
Share price
-0.27%
Change (1 day)
9.81%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement